ArticleInvestigational new drugs2017

Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.

Valentine Heidelberger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.